QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 b-of-a-securities-maintains-buy-on-turnstone-biologics-lowers-price-target-to-10

B of A Securities analyst Geoff Meacham maintains Turnstone Biologics (NASDAQ:TSBX) with a Buy and lowers the price target f...

 piper-sandler-maintains-overweight-on-turnstone-biologics-lowers-price-target-to-375

Piper Sandler analyst Joseph Catanzaro maintains Turnstone Biologics (NASDAQ:TSBX) with a Overweight and lowers the price ta...

 turnstone-biologics-shifts-focus-to-high-unmet-medical-need-cancers-shares-initial-data-from-colorectal-cancer-cell-therapy-study

Turnstone Biologics stock drops after Phase 1 STARLING trial data reveals mixed results for TIDAL-01 in metastatic colorectal c...

 turnstone-biologics-q2-eps-092-misses-084-estimate

Turnstone Biologics (NASDAQ:TSBX) reported quarterly losses of $(0.92) per share which missed the analyst consensus estimate of...

 turnstone-biologics-reports-initial-data-from-phase-1-trial-of-tidal-01-in-metastatic-colorectal-cancer-overall-response-rate-of-25-and-50-disease-control-rate-observed-in-first-4-evaluable-patients

Overall response rate ("ORR") of 25% and 50% disease control rate ("DCR") observed in first four evaluable pati...

 turnstone-biologics-q1-eps-085-misses-078-estimate

Turnstone Biologics (NASDAQ:TSBX) reported quarterly losses of $(0.85) per share which missed the analyst consensus estimate of...

 turnstone-biologics-q4-eps-073-beats-086-estimate

Turnstone Biologics (NASDAQ:TSBX) reported quarterly losses of $(0.73) per share which beat the analyst consensus estimate of $...

 turnstone-biologics-q3-eps-100-up-from-615-yoy-cash-cash-equivalents-and-short-term-investments-1091m

Turnstone Biologics (NASDAQ:TSBX) reported quarterly losses of $(1.00) per share. This is a 83.74 percent increase over losses ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION